Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Mallinckrodt
McKesson
McKinsey
Harvard Business School
Colorcon
AstraZeneca

Last Updated: November 12, 2019

DrugPatentWatch Database Preview

Patent: 9,534,058

See Plans and Pricing

« Back to Dashboard

Summary for Patent: 9,534,058
Title:Anti-CD324 monoclonal antibodies and uses thereof
Abstract: Novel modulators, including antibodies and derivatives thereof, and methods of using such modulators to treat proliferative disorders are provided.
Inventor(s): Stull; Robert A. (Alameda, CA), Aujay; Monette (San Francisco, CA), Foord; Orit (Foster City, CA), Bankovich; Alex (San Francisco, CA), Hampl; Johannes (Santa Clara, CA), Dylla; Scott J. (Emerald Hills, CA), Liu; David (San Francisco, CA)
Assignee: ABBVIE STEMCENTRX LLC (North Chicago, IL)
Application Number:14/377,343
Patent Claims:see list of patent claims

Details for Patent 9,534,058

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Genentech RITUXAN rituximab VIAL 103705 001 1997-11-26   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX search
Genentech HERCEPTIN trastuzumab VIAL; INTRAVENOUS 103792 001 1998-09-25   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 001 2001-05-07   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX Orphan search
Genzyme CAMPATH alemtuzumab VIAL; INTRAVENOUS 103948 002 2001-05-07   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX Orphan search
Genzyme LEMTRADA alemtuzumab INJECTABLE;INJECTION 103948 003 2001-05-07   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX Orphan search
Imclone ERBITUX cetuximab VIAL; INTRAVENOUS 125084 001 2004-06-18   Start Trial ABBVIE STEMCENTRX LLC (North Chicago, IL) 2032-02-08 RX Orphan search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Mallinckrodt
Moodys
Medtronic
Express Scripts
McKesson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.